Anondita Medicare to Showcase at Pharma Eurasia 2026
Anondita Medicare Limited will display its manufacturing capabilities at Pharma Eurasia 2026 in Uzbekistan, aiming to expand its presence in Central Asia and engage with potential buyers. The exhibition, scheduled for May 20-22, will feature opportunities to explore new business partnerships and enhance global visibility.
Anondita Medicare Limited has announced its participation in the upcoming Pharma Eurasia 2026 in Uzbekistan. The event, scheduled for May 20-22 at Tashkent Pharma Park, marks a significant opportunity for the company to expand its footprint in Central Asian markets.
Participating in the exhibition allows Anondita Medicare to showcase its manufacturing capabilities and product portfolio to potential buyers and partners. The company's initiative demonstrates a strategic move to engage with new business prospects and increase its visibility in international markets.
Led by Mr. Anupam Ghosh, with over 25 years in the healthcare industry, Anondita Medicare aims to leverage its expertise and production efficiency for scalable growth. The company is also focusing on automation-led capacity enhancements and launching patented products to ensure its long-term value creation.
(With inputs from agencies.)

